Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.22.1
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income available to stockholders $ 89,409 $ 1,766,707
Weighted average shares outstanding - basic 24,850,261 24,850,261
Effect of dilutive securities:    
Weighted average shares outstanding - Diluted 25,028,616 25,122,271
Net income (loss) per share - basic (in USD per share) $ 0.00 $ 0.07
Net income (loss) per share - diluted (in usd per share) $ 0.00 $ 0.07
Stock Options    
Effect of dilutive securities:    
Stock options 178,355 272,010
Anti-dilutive shares underlying stock options outstanding 928,271 777,296